pharmaceutical daily

– Financing to Advance Lead Development Program, INZ-701, through Clinical Proof of Concept in Two Indications – – Company Expands…

HALIFAX, Nova Scotia–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24IMV&src=ctag" target="_blank"gt;$IMVlt;/agt; lt;a href="https://twitter.com/hashtag/AntibioticDeveloper?src=hash" target="_blank"gt;#AntibioticDeveloperlt;/agt;–Pharmaceutical company Appili Therapeutics Inc. (“Appili” or the “Company”) announced today that…

Acceptance for late breaking oral presentation underscores the oncology community’s interest in Namodenoson as a potential treatment for liver cancer…

DUBLIN–(BUSINESS WIRE)–The “Breakthroughs in Non-Alcoholic Steatohepatitis Management” report has been added to ResearchAndMarkets.com’s offering. Non-Alcoholic Steatohepatitis or NASH is a…

LEXINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CNCE&src=ctag" target="_blank"gt;$CNCElt;/agt; lt;a href="https://twitter.com/hashtag/CNCE?src=hash" target="_blank"gt;#CNCElt;/agt;–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated an additional…

Financing to drive leadership in AAV vector-delivered one-time therapies for major chronic pet health conditions Company supported by leading life…

Series A financing led by two leading global venture capital firms – Sequoia Capital China and Highlight Capital SAN DIEGO–(BUSINESS…